Literature DB >> 19456269

Inflammation and the pathogenesis of age-related macular degeneration.

Albert J Augustin1, Janna Kirchhof.   

Abstract

BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of blindness in the Western world. Many changes occur in various areas of the eye as it ages. These include choroidal thinning, thickening of Bruch's membrane and drusen formation. Each of these is associated with the onset of AMD.
METHODS: Recent findings on how those changes contribute to the pathogenesis of AMD with a focus on inflammation are examined.
RESULTS: There is evidence suggesting that all changes identified so far as being involved in the pathogenesis of AMD are not able to cause AMD alone. Instead, susceptibility genes, and in particular a coding variant of a gene on chromosome 1 result in dysfunction of the immune system. This leads to an inappropriate inflammatory response, which then sets the stage for AMD onset.
CONCLUSIONS: It is now well-known that AMD is a multi-factorial disease, with environmental causes and genetics all playing a role.

Entities:  

Mesh:

Year:  2009        PMID: 19456269     DOI: 10.1517/14728220902942322

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  32 in total

1.  ABCA1 rs1883025 polymorphism and risk of age-related macular degeneration.

Authors:  Yafeng Wang; Mingxu Wang; Yue Han; Rui Zhang; Le Ma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-25       Impact factor: 3.117

2.  Reconsidering the connection between vitamin D levels and age-related macular degeneration.

Authors:  S Golan; V Shalev; G Treister; G Chodick; A Loewenstein
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

3.  C-reactive protein and complement factor H polymorphism interaction in advanced exudative age-related macular degeneration.

Authors:  Roham Soheilian; Mohammad Hossein Jabbarpour Bonyadi; Hamidreza Moein; Mojgan Babanejad; Alireza Ramezani; Mehdi Yaseri; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2016-10-24       Impact factor: 2.031

4.  A2E accumulation influences retinal microglial activation and complement regulation.

Authors:  Wenxin Ma; Steven Coon; Lian Zhao; Robert N Fariss; Wai T Wong
Journal:  Neurobiol Aging       Date:  2012-07-20       Impact factor: 4.673

Review 5.  Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders.

Authors:  Isabel Pascual-Camps; Pablo Hernández-Martínez; Laura Monje-Fernández; Rosa Dolz-Marco; Roberto Gallego-Pinazo; Lihteh Wu; J Fernando Arévalo; Manuel Díaz-Llopis
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-10-15

6.  A modified treat-and-extend regimen of aflibercept for treatment-naïve patients with neovascular age-related macular degeneration.

Authors:  Masayuki Ohnaka; Yoshimi Nagai; Kenichiro Sho; Katsuaki Miki; Motoki Kimura; Tomoyuki Chihara; Kanji Takahashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-14       Impact factor: 3.117

7.  Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets.

Authors:  Karen A Weikel; Paul Fitzgerald; Fu Shang; M Andrea Caceres; Qingning Bian; James T Handa; Alan W Stitt; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-02       Impact factor: 4.799

8.  γ-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines.

Authors:  Xiaoping Qi; Jun Cai; Qing Ruan; Li Liu; Sanford L Boye; Zhijuan Chen; William W Hauswirth; Renee C Ryals; Lynn Shaw; Sergio Caballero; Maria B Grant; Michael E Boulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-01       Impact factor: 4.799

9.  Use of nepafenac (Nevanac) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections.

Authors:  Eric Chen; Matthew S Benz; Richard H Fish; David M Brown; Tien P Wong; Rosa Y Kim; James C Major
Journal:  Clin Ophthalmol       Date:  2010-10-28

10.  Broad spectrum antiangiogenic treatment for ocular neovascular diseases.

Authors:  Ofra Benny; Kei Nakai; Takeru Yoshimura; Lauren Bazinet; James D Akula; Shintaro Nakao; Ali Hafezi-Moghadam; Dipak Panigrahy; Pouya Pakneshan; Robert J D'Amato
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.